Congratulations to Nicola Pozzi, Ph.D., Research Associate in the department, whose company, Hemadvance, was awarded a $50,000 Arch Grant in the 2015 Winter Global Startup Competition. Hemadvance was one of 11 other companies that received grants. The mission of Hemadvance is to develop new ways to diagnose, manage, and treat cardiovascular disorders.
Arch Grants are awarded twice per year and aim to attract and retain innovative entrepreneurs to the St. Louis area. The awardees were announced in several publications, including the St. Louis Business Journal.